top of page

An AI-Powered Discovery Engine
for the Development of
Advanced Immune Therapeutics

Home: Welcome

Flex-NK™ Bispecific Antibodies to Redirect
& Activate NK Cells At the Tumor Site

Screenshot 2023-10-17 at 16.22.11.png

Cytovia Therapeutics R&D Team Presents Poster at ASGCT 2023 on GPC3-Targeted TALEN® Gene-Edited CAR-iNK Cell

April 17th, 2023

Cytovia Therapeutics R&D Team Presents 2 Posters at AACR 2023 on GPC3-Targeted Bispecific Antibody & TALEN® Gene-Edited iNK Cells

April 17th, 2023

See All News & Events

Cytovia Therapeutics R&D Leadership Presents Updated Data at Innate Killer Summit in San Diego

March 31st, 2023

What's New at Cytovia

bottom of page